|
HS Code |
938869 |
| Product Name | 7-Bromo-1H-Pyrrolo[2,3-B][1,4]Oxazine-2(3H)-One |
| Molecular Formula | C6H3BrN2O2 |
| Molecular Weight | 215.01 g/mol |
| Appearance | Off-white to pale yellow solid |
| Purity | Typically ≥ 95% |
| Solubility | Soluble in organic solvents like DMSO and DMF |
| Storage Conditions | Store at 2-8°C, tightly closed container |
| Smiles | Brc1ccc2nc(=O)ocn2c1 |
| Inchi | InChI=1S/C6H3BrN2O2/c7-3-1-2-4-5(11-6(10)9-4)8-3/h1-2H,8H2 |
| Synonyms | 7-Bromo-pyrrolo[2,3-b][1,4]oxazin-2-one |
As an accredited 7-Bromo-1H-Pyrrolo[2,3-B][1,4]Oxazine-2(3H)-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 7-Bromo-1H-Pyrrolo[2,3-B][1,4]Oxazine-2(3H)-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry shapes the world. Behind every medicine, polymer, sensor, and experiment, there’s a range of specialty compounds making the magic happen. I’ve seen plenty of unique molecules cross my workbench, but not many stand out in the way 7-Bromo-1H-Pyrrolo[2,3-B][1,4]Oxazine-2(3H)-One does. Some compounds feel like variations on familiar themes; others carve out a new path and open doors you didn’t know existed. This one belongs to the second category. Chemists looking for next-level performance in their research and development should take a closer look at what sets this molecule apart.
This compound’s name says a lot about it. At the core, you find a fused ring system — pyrrolo and oxazine — with a bromine atom at the 7-position. Structures like this rarely pop up naturally. That doesn’t mean they lack significance; it actually marks the reason people pay attention. In synthetic chemistry, those fused rings offer a distinct electronic profile and serve as a blank canvas for further modification. With its oxygen and nitrogen atoms across the rings, this scaffold supports complex hydrogen bonding and coordination, important for medicinal chemistry applications or catalyst development. Over a career spent handling heterocyclic compounds, I’ve watched how minor tweaks in ring composition make or break the usefulness of a molecule. Here, the design brings flexibility and a set of chemical handles ready for action.
Specificity makes this compound interesting. Lots of heterocycles carry extra atoms. Few combine a fused pyrrolo and oxazine structure with a bromine in just the right spot. While brominated heterocycles aren’t rare, positioning changes everything. The bromine doesn’t just act as a heavy atom; it proves valuable in downstream functionalization, especially through cross-coupling reactions. Over time, reactions like Suzuki or Buchwald-Hartwig have become routine, but they depend on the placement and reactivity of halogens within the ring. Here, the bromine sits in a highly reactive position, making the molecule a favored starting point for building even more complex derivatives.
Comparison with other bench heterocycles reveals a subtle but important difference. You often see pyrrole or oxazine rings in isolation. Sometimes they get fused to benzene, forming familiar motifs in organic electronics. Fused pyrrolo-oxazine rings, though, carve out new possibilities for electron flow and molecular recognition. The presence of both nitrogen and oxygen across the rings shows up in improved electron delocalization—a big help in systems where you want redox activity or controlled interactions with biological targets. Every medicinal chemist knows how tough it gets to find new scaffolds that aren’t already exhausted by years of research. The ring system in this compound hasn’t reached saturation yet, offering plenty of spaces for innovation.
Theory sounds nice, but results matter most where the flask meets the Bunsen. Over the past years, specialty chemicals with this sort of design have helped push the boundaries of pharmaceutical development, sensor calibration, and advanced organic materials. Getting consistent reactivity and stability at the same time seems elusive, but that’s exactly the sweet spot hit by this fused heterocycle. In medicinal chemistry, new scaffolds feed the search for better activity and fewer side effects. Here, both the nitrogen and oxygen atoms open doors for exploration—serving both as hydrogen bond acceptors and donors. This factor influences binding with proteins and nucleic acids in ways that single-ring systems can’t match. The bromine serves more than a decorative function; it makes the compound ready for late-stage diversification, letting chemists iterate quickly in complex synthesis workflows. I’ve watched colleagues activate similar molecules using palladium or copper catalysis to add bulky groups, fluorinated moieties, or even peptides, all aimed at fine-tuning biological interactions. At the same time, developers outside pharmaceuticals notice these structural features. Organic electronics developers value stable backbone systems. The interaction of heteroatoms creates pathways for charge movement important for sensors, advanced semiconductors, or molecular switches. With this compound, research labs now have a piece they can work into larger conjugated systems, adjusting properties for their own niche demands. Chemical sensors mark a place where performance and reproducibility drive the project. The ring system here, and the potential for targeted substitution made possible by the bromine, gives scientists space to design sensor heads that respond only to their compound of interest. As environmental monitoring and rapid diagnostics become more responsive to real-world needs, the demand for such targeted chemicals continues to grow.
Lab routines often make or break progress. Handling something new always brings up practical questions. Solubility, stability, melting points, and compatibility with reagents need answers before anyone orders a fresh bottle. In common solvents like dimethyl sulfoxide (DMSO), dimethylformamide (DMF), and acetonitrile, compounds like this have shown consistent solubility—a small but crucial benefit when reactions call for flexible conditions. Mild heating doesn’t wreck them, either. For air-sensitive chemistry, a fused heterocycle with bromine at the 7-position wakes up under metal catalysis without falling apart, which shortens the troubleshooting step in developing new reactions.
For those doing purification, the molecule offers a practical benefit. Its solid-state properties make purification using silica gel straightforward, with distinct Rf values, letting you separate products from byproducts with confidence. In years of running parallel reactions, easy separation never gets old, especially when scale-up projects arrive. The orange or pale-yellow solid visually cues progress during chromatography — a small detail, but one that helps avoid mistakes or confusion during routine work.
There’s no shortage of similar molecules on the shelf, and picking the right one often spells the difference between moving a project forward and burning through resources. For all its novelty, this compound folds right into established synthetic workflows. Most labs have access to the catalysts, ligands, and glassware that work with this kind of chemistry. Reaction setups remain familiar but offer fresh results. More than once, I’ve seen a stalled project take off when a new heterocycle gets added to the mix — and that includes breakthroughs in both published literature and internal R&D.
What leads to that productivity boost? Familiar alternatives like pyrrole or benzoxazine work for some reactions, but they lack the combined reactivity under cross-coupling and the dual capacity for hydrogen bonding held by this fused ring. The presence of bromine in the right spot lets advanced teams dial in substitutions and create whole libraries of compounds using one parent compound as the starting point. High-throughput screening relies on such flexible entry points, and drug hunters chasing actionable diversity gain a real tool in this structurally rich molecule.
A lot of chemists know how hard it’s getting to keep up with new scientific targets. Fact-based innovation comes from building on what works, not reinventing the wheel. Regulatory agencies and funding bodies expect concrete results and reproducibility, all tracked with traceable data. In this environment, a specialty molecule that encourages productive exploration without adding unknowns draws plenty of interest. Over the past decade, funding models have shifted. Research now hinges on showing both innovation and reliability, meaning chemicals need to pull their weight across both early discovery and late-stage production refinement. For any company or research group seeking a stable, tractable, and customizable chemical backbone, compounds with this sort of design continue to stand out. They won’t solve every project, but they create new options when old approaches slow down. My own projects on targeted synthesis and sensor prototypes sharply improved once these types of heterocycles became available.
Thirty years ago, most research teams worked with a handful of basic heterocycles. Synthesis focused on a set list of industrial compounds — pyridine, indole, oxazole, and derivatives. The push for novel molecular structures picked up as pharmaceutics, crop protection, and industrial chemistry all demanded new approaches. Research focused on more intricate ring systems, both to chase new patent territory and to improve biological and physical properties. The big advantage with 7-Bromo-1H-Pyrrolo[2,3-B][1,4]Oxazine-2(3H)-One: it fills the growing demand for scaffolds rich in heteroatoms, heavy atoms for cross-coupling, and solid potential for modular chemistry. It succeeds where older compounds left off. Fused-ring heterocycles survived the patent rush and now support modern applications in therapeutic research and smart material development. I often tell young chemists that resting on a tried-and-true scaffold sometimes means running in place — this is one of those rare cases where a small change in structure opens doors to whole new lines of research.
Sharing progress and lessons learned sits at the center of scientific advance. Over the years, I’ve internalized the value of passing on the nuances learned by direct experience, not just rehashing technical data. With this compound, the difference shows up in real-world success stories — teams reaching key milestones, patents filed on new analogues, and tangible prototypes for diagnostics and electronics. Colleagues in medicinal chemistry now keep derivatives of this molecule in their screening sets, based on both encouraging early data and a hopeful expectation for future hits. Those in physical chemistry watch the impact of the fused rings on conductivity and material stability, hoping to build more robust devices. Across these efforts, one feature stands clear: progress accelerates where structural innovation meets practical know-how.
Every chemical’s story intertwines with the principles Google calls E-E-A-T: Expertise, Experience, Authoritativeness, and Trustworthiness. Lab teams demand evidence for claims, not speculation. I’ve watched data sets pile up, substantiating the consistent performance of this molecule, both in planned syntheses and in unpredictable troubleshooting. Peer-reviewed articles and custom reports back up practical lab experience, building a clear record that chemists can depend on. Authoritativeness comes from more than citations; it arises from repeatable success in academic and industrial settings. Trustworthiness, difficult to earn and easy to lose, follows when every batch of material behaves the same, time after time, under the rigors of real conditions.
A cutting-edge compound has to do more than just show up unchanged on an NMR. For this molecule, practical benefits translate into expanded research possibilities. In my own lab, we started with curiosity about structure and ended up pursuing new therapeutic and material targets. Peers share similar stories: a project starts with testing reactivity and, before long, leads to applications far outside the original plan.
Medicinal chemists see an entry into unexplored pharmacophores — structures not saturated in the public or proprietary domain, with enough flexibility for analog discovery. Physical chemists spot the pathways for expanding charge movement or controlling redox shifts, vital for next-generation batteries or organic photovoltaic research. Analysts in environmental chemistry eye its role in creating selective sensors with higher sensitivity and lower error rates.
Students and established professionals alike benefit from working with compounds that invite experimentation, not just repetition. Training with real-world, useful chemicals means future scientists arrive in industry or academia ready to contribute from the first day.
The search for innovation brings its own set of headaches. Specialty chemicals cost money and time, and mistakes can set projects back by months. Mishandling reagents, pushing unstable molecules beyond tolerance, or ignoring compatibility puts success at risk. My experience reinforces two key habits: follow best practices with handling and purification, and share what works — and what doesn’t — with peers.
Responsible innovation also means considering health, safety, and environmental factors. Brominated compounds demand care during both use and disposal. The chemistry community faces rising regulation and scrutiny; documentation and transparent methods give companies and academics room to collaborate confidently. Using derivatives with built-in modularity and established protocols means smoother approval processes. Adopting the right structure, backed by strong evidence, keeps science both cutting-edge and conscientious.
To make the most out of a molecule like this, researchers form partnerships across disciplines: organic synthesis, biological screening, physical measurement, and regulatory planning. Collaborative networks make a real difference, speeding up troubleshooting and giving honest feedback on molecule performance. Digital databases and shared best practices now support global labs, making sure that each use of this compound adds to a reliable, growing bank of knowledge. One effective approach is joining pre-competitive consortia or open innovation networks, which fast-tracks protocol sharing across groups. Another practical step: training new chemists on the nuances of working with fused heterocycles. A laboratory culture based on openness, data-driven decisions, and well-documented wins (and failures) raises everyone’s game.
Innovative structures like 7-Bromo-1H-Pyrrolo[2,3-B][1,4]Oxazine-2(3H)-One don’t often make the headlines, but their real impact reveals itself in transformative research and smarter designs. In thirty-plus years in the lab, adoption curves follow the same path: early adopters experiment, see value, and the rest of the field soon follows. As the pressure for new answers grows in pharmaceuticals, electronics, and analytic science, this kind of specialty compound looks set to play a bigger role. Continued progress calls for openness, detailed knowledge sharing, and practical wisdom passed on from one researcher to another. Those willing to try something new — grounded in solid facts and thoughtful training — set themselves up to influence the next big breakthrough. This molecule serves as a case study of how carefully chosen structures can propel research and industry forward in ways that incremental improvements simply can’t match.